Research findings from the PTE Initiative have led to many scientific successes that are now being advanced through new initiative.
View this email in your browser ([link removed])
** Special Edition: 25th Anniversary
CURE Epilepsy Discovery
------------------------------------------------------------
[link removed]
** CURE Epilepsy Discovery: Better Understanding of Post-Traumatic Epilepsy Provides Foundation for the Development of Novel Therapies
------------------------------------------------------------
CURE Epilepsy’s research findings from the PTE Initiative have led to many scientific successes ([link removed]) to date that are now being advanced through the newest team science initiative, the PTE Astrocyte Biomarker Initiative.
Many issues make post-traumatic epilepsy (PTE) a challenging epilepsy to study in laboratories and clinical settings. One of these issues is the process of epileptogenesis, which is the time between the injury and when the brain starts generating seizures and can span days to months or years. Epileptogenesis could provide a unique window of opportunity for intervention, but at present, we do not know enough about this process to develop therapies to halt it in its tracks. Therefore, in order to develop effective treatment strategies to prevent PTE, we need to understand the changes taking place in the brain after TBI and before the development of PTE. Additionally, a PTE biomarker (a biological factor that can be measured through genomic analysis, in blood, or via brain activity that can indicate the potential of developing of PTE) would be especially helpful. Addressing these needs may be best approached in a cohesive effort within the scientific community in order to find effective
preventive strategies and treatments for all individuals at risk of this type of epilepsy.
One way of bringing researchers together in an intentional way is through a “team science” approach. Team science is a collaborative effort where different researchers with a breadth of skills come together to solve a single issue, taking advantage of diversity of scientific background, knowledge and expertise.[7] CURE Epilepsy has a track record of funding team science initiatives, such as the Infantile Spasms (IS) Initiative ([link removed]) , which brought together eight different research teams across the US with an array of expertise to advance the understanding of IS and potential treatments. Team science initiatives provide a unique opportunity for transparent and real-time collaboration.[8]
Read More ([link removed])
============================================================
Today's CURE Epilepsy Discovery has the ability to help the 65 million people worldwide
who are impacted by epilepsy every day.
And each one of those individuals has a story.
** ([link removed])
** Hear Anu's story ([link removed])
** Facebook ([link removed])
** LinkedIn ([link removed])
** Twitter ([link removed])
** Instagram ([link removed])
** YouTube ([link removed])
Our mission is to find a cure for epilepsy, by promoting and funding patient-focused research. CURE Epilepsy is a non-profit 501(c)(3) tax-exempt organization.Our tax identification number is 36-4253176.
** ([link removed])
Copyright © 2022 CURE Epilepsy, All rights reserved.
In the past you provided CURE Epilepsy your email address. Occasionally, you will receive updates from us about epilepsy research and news.
Our mailing address is:
CURE Epilepsy
420 Wabash Ave, Ste 650
Chicago, IL 60611
** Add us to your address book ([link removed])
Want to change how you receive these emails?
You can ** update your preferences ([link removed])
or ** unsubscribe from this list ([link removed])
** . ([link removed])
